FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2317696856> ?p ?o ?g. }

• W2317696856 endingPage "188" @default.
• W2317696856 startingPage "177" @default.
• W2317696856 abstract "Abstract Aims Loop diuretics are first‐line medications for congestive heart failure (CHF); however, they are associated with serious adverse effects, including decreased renal function, and sympathetic nervous and renin–angiotensin system activation. We tested whether tolvaptan, a vasopressin V2‐receptor antagonist, could reduce unfavourable furosemide‐induced effects during CHF treatment. Methods and results Sixty patients emergently hospitalized owing to CHF‐induced dyspnea were randomly assigned to receive either 40 mg intravenous furosemide daily or 7.5 mg oral tolvaptan for 5 days after admission. Both groups also received intravenous carperitide and canrenoate potassium. As results, baseline patient characteristics were similar between the furosemide ( n = 30) and the tolvaptan ( n = 30) groups, with no significant difference in 5 day urine volume or fluid balance. Brain natriuretic peptide and body weight improvements were similar between groups. However, serum creatinine (Cr) level did not increase, and the incidence of worsening renal function was significantly lower in the tolvaptan group. Consequently, the Cr increase to gain 1000 mL urine was 2.5‐fold lower in the tolvaptan group. Furthermore, the blood urea nitrogen (BUN)/Cr ratio significantly decreased in the tolvaptan group, suggesting that renal perfusion was preserved, and urea reuptake and passive water reabsorption were suppressed following tolvaptan treatment. Although catecholamine improvements after treatment were not significantly different, plasma renin activity was enhanced in the furosemide group. Conclusions As compared with furosemide, tolvaptan in patients with acute heart failure is associated with comparable decongestion, better preservation of renal function and less activation of renin–angiotensin system. (UMIN 000014134)." @default.
• W2317696856 created "2016-06-24" @default.
• W2317696856 creator A5025586377 @default.
• W2317696856 creator A5025823804 @default.
• W2317696856 creator A5035666763 @default.
• W2317696856 creator A5041244956 @default.
• W2317696856 creator A5053229206 @default.
• W2317696856 creator A5074549916 @default.
• W2317696856 creator A5080362649 @default.
• W2317696856 creator A5082589032 @default.
• W2317696856 creator A5086039070 @default.
• W2317696856 creator A5090310297 @default.
• W2317696856 date "2016-03-31" @default.
• W2317696856 modified "2023-10-16" @default.
• W2317696856 title "Randomized pilot trial comparing tolvaptan with furosemide on renal and neurohumoral effects in acute heart failure" @default.
• W2317696856 cites W1501096814 @default.
• W2317696856 cites W1969050170 @default.
• W2317696856 cites W1972159895 @default.
• W2317696856 cites W1972691955 @default.
• W2317696856 cites W1977641966 @default.
• W2317696856 cites W1978616702 @default.
• W2317696856 cites W1981834831 @default.
• W2317696856 cites W1993823264 @default.
• W2317696856 cites W1998721019 @default.
• W2317696856 cites W2007574712 @default.
• W2317696856 cites W2011340962 @default.
• W2317696856 cites W2012160991 @default.
• W2317696856 cites W2013832234 @default.
• W2317696856 cites W2015739664 @default.
• W2317696856 cites W2018573712 @default.
• W2317696856 cites W2030557766 @default.
• W2317696856 cites W2048384958 @default.
• W2317696856 cites W2048936478 @default.
• W2317696856 cites W2052953200 @default.
• W2317696856 cites W2056734891 @default.
• W2317696856 cites W2056893352 @default.
• W2317696856 cites W2059717547 @default.
• W2317696856 cites W2061583392 @default.
• W2317696856 cites W2066720046 @default.
• W2317696856 cites W2080823491 @default.
• W2317696856 cites W2095475542 @default.
• W2317696856 cites W2098780362 @default.
• W2317696856 cites W2101636040 @default.
• W2317696856 cites W2116296294 @default.
• W2317696856 cites W2123636688 @default.
• W2317696856 cites W2132800785 @default.
• W2317696856 cites W2140292987 @default.
• W2317696856 cites W2145506399 @default.
• W2317696856 cites W2145576907 @default.
• W2317696856 cites W2147575527 @default.
• W2317696856 cites W2165668878 @default.
• W2317696856 cites W2167877384 @default.
• W2317696856 cites W2170898730 @default.
• W2317696856 cites W2172025889 @default.
• W2317696856 cites W2178738676 @default.
• W2317696856 cites W2296998040 @default.
• W2317696856 cites W2323458614 @default.
• W2317696856 cites W2585382523 @default.
• W2317696856 cites W2916392902 @default.
• W2317696856 cites W4210971754 @default.
• W2317696856 cites W4245244523 @default.
• W2317696856 cites W4255009698 @default.
• W2317696856 doi "https://doi.org/10.1002/ehf2.12088" @default.
• W2317696856 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/5071712" @default.
• W2317696856 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/27818782" @default.
• W2317696856 hasPublicationYear "2016" @default.
• W2317696856 type Work @default.
• W2317696856 sameAs 2317696856 @default.
• W2317696856 citedByCount "85" @default.
• W2317696856 countsByYear W23176968562017 @default.
• W2317696856 countsByYear W23176968562018 @default.
• W2317696856 countsByYear W23176968562019 @default.
• W2317696856 countsByYear W23176968562020 @default.
• W2317696856 countsByYear W23176968562021 @default.
• W2317696856 countsByYear W23176968562022 @default.
• W2317696856 countsByYear W23176968562023 @default.
• W2317696856 crossrefType "journal-article" @default.
• W2317696856 hasAuthorship W2317696856A5025586377 @default.
• W2317696856 hasAuthorship W2317696856A5025823804 @default.
• W2317696856 hasAuthorship W2317696856A5035666763 @default.
• W2317696856 hasAuthorship W2317696856A5041244956 @default.
• W2317696856 hasAuthorship W2317696856A5053229206 @default.
• W2317696856 hasAuthorship W2317696856A5074549916 @default.
• W2317696856 hasAuthorship W2317696856A5080362649 @default.
• W2317696856 hasAuthorship W2317696856A5082589032 @default.
• W2317696856 hasAuthorship W2317696856A5086039070 @default.
• W2317696856 hasAuthorship W2317696856A5090310297 @default.
• W2317696856 hasBestOaLocation W23176968561 @default.
• W2317696856 hasConcept C126322002 @default.
• W2317696856 hasConcept C126894567 @default.
• W2317696856 hasConcept C134018914 @default.
• W2317696856 hasConcept C138976137 @default.
• W2317696856 hasConcept C159641895 @default.
• W2317696856 hasConcept C164705383 @default.
• W2317696856 hasConcept C198710026 @default.
• W2317696856 hasConcept C2776370428 @default.
• W2317696856 hasConcept C2777955127 @default.
• W2317696856 hasConcept C2778198053 @default.

• next